Categories: Wire Stories

Nidec�s Disaster Relief and Recovery Assistance for Turkey-Syria Earthquake

KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (�Nidec”) would like to extend its deepest sympathy and condolences to the people of Turkey and Syria affected by the devastating earthquake that struck the region on February 6th. As a gesture of goodwill and support, Nidec will donate 10 million yen through the Japanese Red Cross Society to contribute to the ongoing recovery and relief efforts.

Nidec would like to once again express its solidarity and heartfelt thoughts to the victims and those engaged in heroic rescue efforts, as well as its wishes for a swift recovery of the affected areas.

Contacts

Masahiro Nagayasu

General Manager

IR&CSR Promotion

+81-75-935-6550

csr@nidec.com

Alex

Recent Posts

Zhengzhou: Interactive Exhibitions on the International Museum Day

ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…

10 hours ago

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

20 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago